Published in Panminerva Med on December 01, 2010
Molecular analysis of the Noggin (NOG) gene in holoprosencephaly patients. Mol Genet Metab (2012) 0.75
Semi Lobar Holoprosencephaly with Vertebral Segmentation Defects. Iran J Child Neurol (2017) 0.75
Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest (2006) 3.17
Impairment of GH secretion in adults with primary empty sella. J Endocrinol Invest (2002) 2.09
Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara. Endocrine (2012) 1.50
Younger age at diagnosis of type 1 diabetes mellitus in children of immigrated families born in Italy. J Endocrinol Invest (2004) 1.49
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. Clin Endocrinol (Oxf) (1999) 1.48
Circulating ghrelin levels in the newborn are positively associated with gestational age. Clin Endocrinol (Oxf) (2004) 1.44
Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity. J Endocrinol Invest (1994) 1.42
Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab (2004) 1.40
Incidence and prevalence rate estimation of GH treatment exposure in Piedmont pediatric population in the years 2002-2004: Data from the GH Registry. J Endocrinol Invest (2006) 1.39
Transition process of patients with type 1 diabetes (T1DM) from paediatric to the adult health care service: a hospital-based approach. Clin Endocrinol (Oxf) (2008) 1.30
Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol (Oxf) (2011) 1.25
Primary empty sella: Why and when to investigate hypothalamic-pituitary function. J Endocrinol Invest (2010) 1.21
Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. Int J Obes Relat Metab Disord (1999) 1.11
Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: comparison with conventional clinical, laboratory, and imaging approaches. J Clin Endocrinol Metab (2001) 1.11
Evidence for gene conversion in the generation of extensive polymorphism in the promoter of the growth hormone gene. Hum Genet (1997) 1.08
Consensus guidelines on screening for hypopituitarism following traumatic brain injury. Brain Inj (2005) 1.05
Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab (1996) 1.03
Diagnosis of adult GH deficiency. Growth Horm IGF Res (2007) 1.01
Neonatal transient hypothyroidism: aetiological study. Italian Collaborative Study on Transient Hypothyroidism. Arch Dis Child Fetal Neonatal Ed (1998) 1.00
Apomixis and sexuality in Paspalum simplex: characterization of the mode of reproduction in segregating progenies by different methods. Sex Plant Reprod (2001) 0.99
Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children. Clin Endocrinol (Oxf) (2006) 0.98
Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. J Clin Endocrinol Metab (2000) 0.97
Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH. Eur J Endocrinol (2001) 0.94
New approach to the diagnosis of growth hormone deficiency in adults. Eur J Endocrinol (1996) 0.94
Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans. J Endocrinol Invest (2003) 0.92
Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes (2001) 0.91
The incidence of type 1 diabetes is increasing in both children and young adults in Northern Italy: 1984-2004 temporal trends. Diabetologia (2009) 0.91
Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans. J Clin Endocrinol Metab (2003) 0.90
Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab (1999) 0.90
Comparative mapping reveals partial conservation of synteny at the apomixis locus in Paspalum spp. Mol Genet Genomics (2003) 0.89
Foetal and neonatal thyroid disorders. Minerva Pediatr (2002) 0.89
The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids. J Clin Endocrinol Metab (1997) 0.89
Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults. Endocrine (2001) 0.89
Detoxification process for glutaraldehyde-treated bovine pericardium: biological, chemical and mechanical characterization. J Heart Valve Dis (1998) 0.88
Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. J Clin Endocrinol Metab (2003) 0.88
Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. Eur J Endocrinol (2012) 0.88
Ghrelin gene polymorphisms and ghrelin, insulin, IGF-I, leptin and anthropometric data in children and adolescents. Eur J Endocrinol (2004) 0.87
Hypopituitarism induced by traumatic brain injury in the transition phase. J Endocrinol Invest (2005) 0.87
Telecare for teenagers with type 1 diabetes: a trial. Minerva Pediatr (2007) 0.87
Diagnosis of adult GH deficiency. Pituitary (2008) 0.87
Noonan-like syndrome with loose anagen hair associated with growth hormone insensitivity and atypical neurological manifestations. Am J Med Genet A (2012) 0.87
Puberty onset in Northern Italy: a random sample of 3597 Italian children. J Endocrinol Invest (2005) 0.86
Ghrelin: from somatotrope secretion to new perspectives in the regulation of peripheral metabolic functions. Front Horm Res (2006) 0.86
A systematic review of Helicobacter pylori eradication treatment schedules in children. Aliment Pharmacol Ther (2000) 0.86
Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism. J Clin Endocrinol Metab (2001) 0.86
Ghrelin: endocrine, metabolic and cardiovascular actions. J Endocrinol Invest (2005) 0.85
Endocrine dysfunction in patients operated on for non-pituitary intracranial tumors. Eur J Endocrinol (2006) 0.85
Prevalence and risk factors for overweight and obesity in a population of Italian schoolchildren: a longitudinal study. J Endocrinol Invest (2008) 0.85
EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man. J Endocrinol Invest (2002) 0.85
Hypopituitarism following traumatic brain injury. Front Horm Res (2005) 0.84
Early onset of gastric carcinoma and constitutional deletion of 18p. Cancer Genet Cytogenet (1999) 0.84
The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J Clin Endocrinol Metab (2003) 0.84
Vitamin D levels in a paediatric population of normal weight and obese subjects. J Endocrinol Invest (2014) 0.84
Control of metalloprotein reduction potential: the role of electrostatic and solvation effects probed on plastocyanin mutants. Biochemistry (2001) 0.83
Growth hormone receptor gene mutations in two Italian patients with Laron Syndrome. J Endocrinol Invest (2007) 0.83
Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. Int J Obes Relat Metab Disord (2001) 0.83
Cardiac effects of hexarelin in hypopituitary adults. Eur J Pharmacol (1999) 0.83
The use of local reference growth charts for clinical use or a universal standard: a balanced appraisal. J Endocrinol Invest (2012) 0.83
Pituitary imaging abnormalities in patients with and without hypopituitarism after traumatic brain injury. J Endocrinol Invest (2007) 0.83
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. Am J Physiol (1999) 0.82
Hypopituitarism following traumatic brain injury. Growth Horm IGF Res (2005) 0.82
Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test. J Endocrinol Invest (1999) 0.82
Lipid profile and nutritional intake in children and adolescents with Type 1 diabetes improve after a structured dietician training to a Mediterranean-style diet. J Endocrinol Invest (2011) 0.82
Retesting the childhood-onset GH-deficient patient. Eur J Endocrinol (2008) 0.82
Loss of expression of the oncosuppressor PTEN in thyroid incidentalomas associates with GLUT1 plasmamembrane expression. Panminerva Med (2012) 0.82
Occurrence of GH deficiency in adult patients who underwent neurosurgery in the hypothalamus-pituitary area for non-functioning tumour masses. Growth Horm IGF Res (2003) 0.81
Retention of nativelike conformation by proteins embedded in high external electric fields. J Chem Phys (2005) 0.81
Growth hormone therapy for short children born small for gestational age. Horm Res (2007) 0.81
The IGF-I response to very low rhGH doses is preserved in human ageing. Clin Endocrinol (Oxf) (1998) 0.81
Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma. J Clin Endocrinol Metab (2006) 0.81
Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan. Eur J Endocrinol (1996) 0.81
Manifesto for the current understanding and management of traumatic brain injury-induced hypopituitarism. J Endocrinol Invest (2011) 0.81
Circulating ghrelin levels as function of gender, pubertal status and adiposity in childhood. J Endocrinol Invest (2002) 0.80
Ghrelin secretion in preterm neonates progressively increases and is refractory to the inhibitory effect of food intake. J Clin Endocrinol Metab (2006) 0.80
Activity of GH/IGF-1 axis in burn patients: comparison with normal subjects and patients with GH deficiency. J Endocrinol Invest (2002) 0.80
Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism. Growth Horm IGF Res (2013) 0.79
Ghrelin: a link between eating disorders, obesity and reproduction. Nutr Neurosci (2005) 0.79
Acylated/unacylated ghrelin ratio in cord blood: correlation with anthropometric and metabolic parameters and pediatric lifespan comparison. Eur J Endocrinol (2011) 0.79
[Neurofibromatosis type 1 and hypertension in pediatrics: case report]. Minerva Pediatr (2011) 0.79
Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects. Baillieres Clin Endocrinol Metab (1998) 0.79
Acylated and unacylated ghrelin levels in normal weight and obese children: influence of puberty and relationship with insulin, leptin and adiponectin levels. J Endocrinol Invest (2011) 0.79